Seres Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Seres Therapeutics, Inc. (MCRB) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 92.16 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-04.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-04
- Seres Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 92.16M shares, a 0.70% increase year-over-year.
- Seres Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 91.66M shares, a 25.04% increase year-over-year.
- Seres Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 91.53M shares, a 29.24% increase year-over-year.
- Seres Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 91.41M shares, a 30.28% increase year-over-year.
- Seres Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 91.70M shares, a 14.93% increase from fiscal 2020.
- Seres Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 79.79M shares, a 40.85% increase from fiscal 2019.
- Seres Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 56.65M shares, a 39.04% increase from fiscal 2018.
- Seres Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 40.74M shares, a 0.73% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|---|
| 2022-03-31 | 92.16M shares 10-Q · filed 2022-05-04 | ||||
| 2021-12-31 | 91.70M shares 10-K · filed 2022-03-01 | ||||
| 2021-06-30 | 91.66M shares 10-Q · filed 2021-08-03 | 91.59M shares 10-Q · filed 2021-08-03 | 91.53M shares derived: average of 3 quarters · filed 2022-05-04 | 89.53M shares derived: average of 4 quarters · filed 2022-05-04 | |
| 2021-03-31 | 91.53M shares 10-Q · filed 2022-05-04 | 91.47M shares derived: average of 2 quarters · filed 2022-05-04 | 88.82M shares derived: average of 3 quarters · filed 2022-05-04 | 84.94M shares derived: average of 4 quarters · filed 2022-05-04 | |
| 2020-12-31 | 91.41M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 87.47M shares derived: average of 2 quarters · filed 2022-03-01 | 82.75M shares derived: average of 3 quarters · filed 2022-03-01 | 79.79M shares 10-K · filed 2022-03-01 | |
| 2020-09-30 | 83.53M shares 10-Q · filed 2020-11-09 | 78.42M shares derived: average of 2 quarters · filed 2021-08-03 | 75.91M shares 10-Q · filed 2020-11-09 | 74.46M shares derived: average of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | 73.31M shares 10-Q · filed 2021-08-03 | 72.06M shares 10-Q · filed 2021-08-03 | 71.43M shares derived: average of 3 quarters · filed 2022-03-01 | 71.06M shares derived: average of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | 70.82M shares 10-Q · filed 2021-05-04 | 70.49M shares derived: average of 2 quarters · filed 2022-03-01 | 70.31M shares derived: average of 3 quarters · filed 2022-03-01 | 64.02M shares derived: average of 4 quarters · filed 2022-03-01 | |
| 2019-12-31 | 70.17M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 70.06M shares derived: average of 2 quarters · filed 2022-03-01 | 61.75M shares derived: average of 3 quarters · filed 2022-03-01 | 56.65M shares 10-K · filed 2022-03-01 | |
| 2019-09-30 | 69.94M shares 10-Q · filed 2020-11-09 | 57.54M shares derived: average of 2 quarters · filed 2020-11-09 | 52.14M shares 10-Q · filed 2020-11-09 | 49.25M shares derived: average of 4 quarters · filed 2021-03-02 | |
| 2019-06-30 | 45.14M shares 10-Q · filed 2020-07-28 | 43.10M shares 10-Q · filed 2020-07-28 | 42.35M shares derived: average of 3 quarters · filed 2021-03-02 | 41.96M shares derived: average of 4 quarters · filed 2021-03-02 | |
| 2019-03-31 | 41.03M shares 10-Q · filed 2020-05-07 | 40.95M shares derived: average of 2 quarters · filed 2021-03-02 | 40.90M shares derived: average of 3 quarters · filed 2021-03-02 | 40.84M shares derived: average of 4 quarters · filed 2021-03-02 | |
| 2018-12-31 | 40.88M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | 40.84M shares derived: average of 2 quarters · filed 2021-03-02 | 40.78M shares derived: average of 3 quarters · filed 2021-03-02 | 40.74M shares 10-K · filed 2021-03-02 | |
| 2018-09-30 | 40.81M shares 10-Q · filed 2019-11-05 | 40.73M shares derived: average of 2 quarters · filed 2019-11-05 | 40.70M shares 10-Q · filed 2019-11-05 | 40.66M shares derived: average of 4 quarters · filed 2020-03-02 | |
| 2018-06-30 | 40.66M shares 10-Q · filed 2019-08-06 | 40.65M shares 10-Q · filed 2019-08-06 | 40.61M shares derived: average of 3 quarters · filed 2020-03-02 | 40.58M shares derived: average of 4 quarters · filed 2020-03-02 | |
| 2018-03-31 | 40.63M shares 10-Q · filed 2019-05-02 | 40.58M shares derived: average of 2 quarters · filed 2020-03-02 | 40.55M shares derived: average of 3 quarters · filed 2020-03-02 | 40.51M shares derived: average of 4 quarters · filed 2020-03-02 | |
| 2017-12-31 | 40.54M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | 40.52M shares derived: average of 2 quarters · filed 2020-03-02 | 40.48M shares derived: average of 3 quarters · filed 2020-03-02 | 40.45M shares 10-K · filed 2020-03-02 | |
| 2017-09-30 | 40.49M shares 10-Q · filed 2018-11-08 | 40.44M shares derived: average of 2 quarters · filed 2018-11-08 | 40.42M shares 10-Q · filed 2018-11-08 | 40.40M shares derived: average of 4 quarters · filed 2019-03-06 | |
| 2017-06-30 | 40.39M shares 10-Q · filed 2018-08-02 | 40.38M shares 10-Q · filed 2018-08-02 | 40.37M shares derived: average of 3 quarters · filed 2019-03-06 | 40.34M shares derived: average of 4 quarters · filed 2019-03-06 | |
| 2017-03-31 | 40.37M shares 10-Q · filed 2018-05-09 | 40.36M shares derived: average of 2 quarters · filed 2019-03-06 | 40.32M shares derived: average of 3 quarters · filed 2019-03-06 | 40.14M shares derived: average of 4 quarters · filed 2019-03-06 | |
| 2016-12-31 | 40.36M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | 40.30M shares derived: average of 2 quarters · filed 2019-03-06 | 40.07M shares derived: average of 3 quarters · filed 2019-03-06 | 39.85M shares 10-K · filed 2019-03-06 | |
| 2016-09-30 | 40.24M shares 10-Q · filed 2017-11-08 | 39.92M shares derived: average of 2 quarters · filed 2017-11-08 | 39.68M shares 10-Q · filed 2017-11-08 | 39.57M shares derived: average of 4 quarters · filed 2018-03-08 | |
| 2016-06-30 | 39.60M shares 10-Q · filed 2017-08-03 | 39.39M shares 10-Q · filed 2017-08-03 | 39.35M shares derived: average of 3 quarters · filed 2018-03-08 | 39.26M shares derived: average of 4 quarters · filed 2018-03-08 | |
| 2016-03-31 | 39.19M shares 10-Q · filed 2017-05-04 | 39.22M shares derived: average of 2 quarters · filed 2018-03-08 | 39.14M shares derived: average of 3 quarters · filed 2018-03-08 | 31.52M shares derived: average of 4 quarters · filed 2018-03-08 | |
| 2015-12-31 | 39.25M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | 39.12M shares derived: average of 2 quarters · filed 2018-03-08 | 28.96M shares derived: average of 3 quarters · filed 2018-03-08 | 23.53M shares 10-K · filed 2018-03-08 | |
| 2015-09-30 | 38.98M shares 10-Q · filed 2016-11-10 | 23.81M shares derived: average of 2 quarters · filed 2016-11-10 | 18.29M shares 10-Q · filed 2016-11-10 | 15.76M shares derived: average of 4 quarters · filed 2017-03-16 | |
| 2015-06-30 | 8.64M shares 10-Q · filed 2015-08-10 | 7.78M shares 10-Q · filed 2016-08-11 | 8.03M shares derived: average of 3 quarters · filed 2017-03-16 | 7.71M shares derived: average of 4 quarters · filed 2017-03-16 | |
| 2015-03-31 | 8.64M shares 10-Q · filed 2016-08-11 | 6.91M shares 10-Q · filed 2016-05-16 | 7.72M shares derived: average of 2 quarters · filed 2017-03-16 | 7.40M shares derived: average of 3 quarters · filed 2017-03-16 | 7.23M shares derived: average of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | 6.80M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | 6.78M shares derived: average of 2 quarters · filed 2017-03-16 | 6.76M shares derived: average of 3 quarters · filed 2017-03-16 | 6.75M shares 10-K · filed 2017-03-16 | |
| 2014-09-30 | 6.77M shares 10-Q · filed 2015-11-12 | 6.75M shares derived: average of 2 quarters · filed 2015-11-12 | 6.73M shares 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | 6.73M shares 10-Q · filed 2015-08-10 | 6.71M shares 10-Q · filed 2015-08-10 | |||
| 2013-12-31 | 6.39M shares 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |